Revolutionizing the fight against infectious disease

Infectious diseases, resulting from bacterial, fungal, parasitic or viral infections, are a leading cause of death worldwide. Our cutting-edge technologies are revolutionizing the identification, tracking, diagnosis and treatment of infectious disease so that patients can get back to living healthy lives.

Learn more

See how we’re applying this technology to fight COVID-19

Play video
Our products

Our products aspire to bring quantum leaps in innovation to the world

Detect

Rapid detection

Recognize active infection and assess infection severity and sepsis within minutes in any setting, including the home.

Learn more
Diagnose

Rapid pathogen identification

Accurately identify infection-causing pathogens, within one hour, without the need for blood cultures.

Learn more
Treat

Pathogen toxin removal

Filter the toxic by-products of pathogens directly from a patient’s blood using an extracorporeal therapeutic filter.

Learn more

The Compassionate Use provision in the regulations provides a path to access investigational products that have not yet received FDA approval or clearance, including the GARNETTM extracorporeal therapeutic that is intended to treat serious and/or life-threatening diseases.

Compassionate Use Policy

Where heart meets mind to solve global health challenges

BOA™ Biomedical was founded to develop tracking, diagnostics and interventions that reduce the threat of infectious disease due to antibiotic resistance, hospital-acquired infection, emergent pandemic threats or bioterrorism. We’re working to empower the global population with technology that detects infection, identifies what’s causing it and diagnoses how serious it is. Better still, our therapeutic can help treat those suffering from deadly conditions like sepsis by removing harmful pathogens and their toxins directly from their bloodstream.

Investment

Help set the world free from fear of infection

This material is being provided for informational purposes and is not to be considered an offer to sell or a solicitation of an offer to buy any interest in any investments referred to herein. Further information may be found here.